How is the Insight Molecular Diagnostics Inc. today?

The Insight Molecular Diagnostics Inc. today is trading in the down by -1.25% at 3.16.

How has Insight Molecular Diagnostics Inc. performed historically?

The Insight Molecular Diagnostics Inc. is currently trading down -1.25% on an intraday basis in the past week the index rose 19.25%. The index has been down -4.24% in the past quarter and rose 10.10% in the past year. You can view this in the overview section.

What is Insight Molecular Diagnostics Inc. Annual Revenue?

Insight Molecular Diagnostics Inc. Annual Revenue rose 25.15%, in the last year to $1.88 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Insight Molecular Diagnostics Inc. Annual Net Profit?

Insight Molecular Diagnostics Inc. Annual Net Profit fell 118.36% in the last year to $60.66 M. Its sector's average net profit growth for the last fiscal year was -14.05%.

What is Insight Molecular Diagnostics Inc. Price to Earning Ratio?

Insight Molecular Diagnostics Inc. Price to Earning Ratio is -1.55, which is negative.

What is Insight Molecular Diagnostics Inc. Stock Price?

Insight Molecular Diagnostics Inc. Stock Price rose 10.1% and underperformed its sector by 145.13% in the past year.

What is Insight Molecular Diagnostics Inc. Quarterly Revenue?

Insight Molecular Diagnostics Inc. Quarterly Revenue rose 1,114.77% YoY to $2.14 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Insight Molecular Diagnostics Inc. Quarterly Net profit?

Insight Molecular Diagnostics Inc. Quarterly Net profit rose 26.93% YoY to $6.67 M. Its sector's average net profit growth YoY for the quarter was -236.06%.

What is Insight Molecular Diagnostics Inc. Return on Equity(ROE)?

Insight Molecular Diagnostics Inc. Return on Equity(ROE) for the last financial year was -1,487.09%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Insight Molecular Diagnostics Inc. Mutual Fund Holding?

Insight Molecular Diagnostics Inc. Mutual Fund Holding increased by 0.39% in the last quarter to 3.35.

What is Insight Molecular Diagnostics Inc. Promoter Share Holding?

Insight Molecular Diagnostics Inc. Promoter Share Holding stayed the same in the most recent quarter at 0.57%.

What is Insight Molecular Diagnostics Inc. Interest Coverage Ratio?

Insight Molecular Diagnostics Inc. Interest Coverage Ratio is -721.18, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Insight Molecular Diagnostics Inc. Institutional Holding?

Insight Molecular Diagnostics Inc. Institutional Holding increased by 26.84% in the last quarter to 56.27.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : BIOTECH
INSIGHT MOLECULAR DIAGNOSTICS INC.

Insight Molecular Diagnostics Inc. XNAS: IMDX

Insight Molecular Diagnostics Inc. Live Share Price Today, Share Analysis and Chart

Name: Insight Molecular Diagnostics Inc.: Is Infosys Ltd. worth buying?
Item: Insight Molecular Diagnostics Inc.
Rating: 1.61983325
Author: Trendlyne DVM scores

about

Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomar...

3.16 -0.04 (-1.25%)

33.47% Fall from 52W High

1.4M

XNAS Volume

High volume today

XNAS 18 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Insight Molecular Diagnostics Inc. is on 27 Jun 2025 for the purpose of OncoCyte Corp Annual General Meeting for 2024 See details

Not Eligible

Expensive Valuation

6.8 / 100

Technically Neutral

58.0 / 100

1Yr Price target upside is 72%

3 analysts

Insight Molecular Diagnost... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Insight Molecular Diagnostics Inc. Live Share Price Today, Share Analysis and Chart

Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomar...

33.47% Fall from 52W High

High volume today

SWOT Analysis

Insight Molecular Diagnost... Live Price Chart

Insight Molecular Diagnostics Inc. FAQ

How is Insight Molecular Diagnostics Inc. today?

Insight Molecular Diagnostics Inc. today is trading in the red, and is down by -1.25% at 3.16.

How has Insight Molecular Diagnostics Inc. performed historically?

Insight Molecular Diagnostics Inc. is currently trading down -1.25% on an intraday basis. In the past week the stock rose 19.25%. stock has been down -4.24% in the past quarter and rose 10.10% in the past year. You can view this in the overview section.